Bliss GVS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

10.47

10.42

10.37

10.31

10.31

Share application money

-

-

9.94

9.84

-

Preference share capital

-

-

-

-

-

Reserves & surplus

977.97

926.58

831.12

735.50

672.63

Loan funds

Secured loans

65.63

77.08

85.61

67.87

71.49

Unsecured loans

-

-

-

-

-

Total

1,054.08

1,014.08

937.04

823.52

754.43

Uses of funds

Fixed assets

Gross block

412.68

384.36

269.03

210.61

202.18

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

82.04

58.86

44.02

35.82

22.63

Net block

330.64

325.50

225.00

174.78

179.55

Capital work-in-progress

7.83

2.80

22.15

2.39

-

Investments

18.69

18.26

18.26

18.30

18.31

Net current assets

Current assets, loans & advances

795.40

793.13

814.55

750.14

657.23

Less : current liabilities & provisions

98.48

125.61

142.92

122.10

100.67

Total net current assets

696.92

667.52

671.63

628.04

556.57

Miscellaneous expenses not written

-

-

-

-

-

Total

1,054.08

1,014.08

937.04

823.52

754.43

Notes:

Book value of unquoted investments

18.69

18.26

18.26

18.30

18.31

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

55.82

10.09

21.81

30.06

14.33

Number of equity sharesoutstanding (Lacs)

1046.91

1041.53

1036.78

1031.47

1031.47